NEW YORK (GenomeWeb News) – Invitrogen has signed a non-binding letter of intent to collaborate with the International Regulome Consortium on the development of stem cell research tools, the firms announced yesterday at the Biotechnology Industry Organization annual meeting in San Diego.
 
Under terms of the pact, Invitrogen will contribute unspecified services and technologies to help IRC researchers map the “genetic circuit board” that regulates how stem cells give rise to specialized cells, such as neurons.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.